UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. __)*
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[_] Rule 13d-1(b)
[X] Rule 13d-1(c)
[_] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
==================== =================
CUSIP No. 26746E103 13G Page 2 of 8 Pages
==================== =================
================================================================================
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS(ENTITIES ONLY).
Lancet Capital Heath Ventures, L.P. (Tax ID: 043427577)
---- --------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_]
(b) [_]
---- --------------------------------------------------------------------------
3. SEC USE ONLY
---- --------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
0
---- -------------------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 1,344,087
OWNED BY ---- -------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH 0
---- -------------------------------------------------------
8. SHARED DISPOSITIVE POWER
1,344,087
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,344,087
---- --------------------------------------------------------------------------
10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_]
---- --------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.5%
---- --------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
PN
================================================================================
|
==================== =================
CUSIP No. 26746E103 13G Page 3 of 8 Pages
==================== =================
================================================================================
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS(ENTITIES ONLY).
Lancet Capital Heath Ventures G.P., LLC (Tax ID: 043427574)
---- --------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_]
(b) [_]
---- --------------------------------------------------------------------------
3. SEC USE ONLY
---- --------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
0
---- -------------------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 1,344,087
OWNED BY ---- -------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH 0
---- -------------------------------------------------------
8. SHARED DISPOSITIVE POWER
1,344,087
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,344,087
---- --------------------------------------------------------------------------
10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_]
---- --------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.5%
---- --------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
CO
================================================================================
|
==================== =================
CUSIP No. 26746E103 13G Page 4 of 8 Pages
==================== =================
================================================================================
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS(ENTITIES ONLY).
William J. Golden
---- --------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_]
(b) [_]
---- --------------------------------------------------------------------------
3. SEC USE ONLY
---- --------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
0
---- -------------------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 1,344,087
OWNED BY ---- -------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH 0
---- -------------------------------------------------------
8. SHARED DISPOSITIVE POWER
1,344,087
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,344,087
---- --------------------------------------------------------------------------
10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_]
---- --------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.5%
---- --------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
IN
================================================================================
|
==================== =================
CUSIP No. 26746E103 13G Page 5 of 8 Pages
==================== =================
================================================================================
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS(ENTITIES ONLY).
George L. Sing
---- --------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_]
(b) [_]
---- --------------------------------------------------------------------------
3. SEC USE ONLY
---- --------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
0
---- -------------------------------------------------------
NUMBER OF 6. SHARED VOTING POWER
SHARES
BENEFICIALLY 1,344,087
OWNED BY ---- -------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH 0
---- -------------------------------------------------------
8. SHARED DISPOSITIVE POWER
1,344,087
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,344,087
---- --------------------------------------------------------------------------
10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_]
---- --------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.5%
---- --------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
IN
================================================================================
|
==================== =================
CUSIP No. 26746E103 13G Page 6 of 8 Pages
==================== =================
ITEM 1.(A) NAME OF ISSUER
Dyax Corporation
ITEM 1.(B) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES
300 Technology Square
Cambridge, MA 02139
ITEM 2.(A) NAME OF PERSONS FILING
This filing is made on behalf of each of Lancet Capital Health
Ventures, L.P., Lancet Capital Health Ventures, G.P., LLC, William
J. Golden, and George L. Sing.
ITEM 2.(B) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE
The principal business office of each reporting person is 124 Mount
Auburn Street, Suite 200N, Cambridge, Massachusetts 02138.
ITEM 2.(C) CITIZENSHIP
Lancet Capital Health Ventures, L.P. and Lancet Capital Health
Ventures, G.P., LLC are organized and exist under the laws of the
State of Delaware. Golden and L. Sing are United States citizens.
ITEM 2.(D) TITLE OF CLASS OF SECURITIES
Common Stock, $.01 par value per share.
ITEM 2.(E) CUSIP NUMBER
26746E103
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TOSS.SS.240.13D-1(B) OR
240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A:
N/A
|
==================== =================
CUSIP No. 26746E103 13G Page 7 of 8 Pages
==================== =================
ITEM 4. OWNERSHIP.
The information contained in Items 5-11 of the cover page is
incorporated herein by reference. Lancet Capital Health Ventures,
L.P. ("Lancet Capital L.P."), is the record owner of the shares of
common stock. Lancet Capital Health Ventures, G.P., LLC ("Lancet
Capital G.P."), in its capacity as general partner of Lancet Capital
L.P., has the power to vote and dispose of the common stock held by
Lancet Capital L.P. Golden and Sing are the managing directors of
Lancet Capital G.P. As such, they each have the power to direct the
voting control of Lancet Capital G.P. While neither Golden nor Sing
own of record any shares of common stock, as a result of their
positions, Golden and Sing may be deemed to be beneficial owners of
and to have the power to exercise or to direct the exercise of
voting and/or dispositive power with respect to the shares reported
herein. Messrs. Golden and Sing disclaim beneficial ownership over
any of the reported securities which they may be been deemed to
beneficially own.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
N/A
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
N/A
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
N/A
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
N/A
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
N/A
ITEM 10. CERTIFICATION
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in
any transaction having that purpose or effect.
|
==================== =================
CUSIP No. 26746E103 13G Page 8 of 8 Pages
==================== =================
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
April 4, 2003 LANCET CAPITAL HEALTH VENTURES, L.P.
By: Lancet Capital Health Ventures G.P., LLC
By: /s/ William J. Golden
--------------------------------
Name: William J. Golden
-----------------------------
Title: Managing Director
----------------------------
April 4, 2003 LANCET CAPITAL HEALTH VENTURES G.P., LLC
By: /s/ William J. Golden
--------------------------------
Name: William J. Golden
-----------------------------
Title: Managing Director
----------------------------
WILLIAM J. GOLDEN
April 4, 2003 /s/ William J. Golden
-----------------------------------
Name: William J. Golden
-----------------------------
GEORGE L. SING
April 4, 2003 /s/ George L. Sing
-----------------------------------
Name: George L. Sing
-----------------------------
|
JOINT FILING AGREEMENT
Lancet Capital Health Ventures, L.P., Lancet Capital Health Ventures, G.P., LLC, William J. Golden, and George L. Sing agree that the Schedule 13G, to which this Agreement is attached, relating to the common stock of Dyax Corporation, is filed on behalf of each of them.
Dated: April 4, 2003 LANCET CAPITAL HEALTH VENTURES, L.P.
By: Lancet Capital Health Ventures G.P., LLC
By: /s/ William J. Golden
--------------------------------
Name: William J. Golden
-----------------------------
Title: Managing Director
----------------------------
Dated: April 4, 2003 LANCET CAPITAL HEALTH VENTURES G.P., LLC
By: /s/ William J. Golden
--------------------------------
Name: William J. Golden
-----------------------------
Title: Managing Director
----------------------------
WILLIAM J. GOLDEN
Dated: April 4, 2003 /s/ William J. Golden
-----------------------------------
Name: William J. Golden
-----------------------------
|
GEORGE L. SING
Dated: April 4, 2003 /s/ George L. Sing
-----------------------------------
Name: George L. Sing
-----------------------------
|